Asia Pacific Phytosterols Market - By Type, Application and Geography-Market Shares, Forecasts and Trends 2017 - 2022

  • ID: 4386930
  • Report
  • Region: Asia, Asia Pacific
  • 101 pages
  • Mordor Intelligence
1 of 3
The Asia pacific countries such as china, Indonesia, Singapore and India are experiencing substantial increase in cardiovascular disease rate due to rapidly changing lifestyle and hence growing public health risk, therefore resulting in potential market for phytosterol industry. One of the strategy for lowering cholesterol and risk of heart diseases is to change the eating habits by replacing Trans and saturated fat from monounsaturated and polyunsaturated fats but this has not been the sufficient step to overcome the health issues, therefore Asia Pacific market is inclining towards phytosterols. It is predicted that, from (2017 - 2022), the global growth of 8.5% in phytosterols market will have major contribution by Asia pacific market.

Europe and North America, are the major players in phytosterols market and have been in top consumer list since many years due to the health conditions of these regions but because of changing scenario and more inclination towards western culture have led Asia pacific countries in bad health conditions. It was recorded that Asians and Pacific islanders were at third highest risk for heart related deaths at 22.5% in 2013. Thus these countries are at more risk and therefore becoming major market for phytosterol industry.

Considering , Australia market , there have been significant increase in the consumption of phytosterols based on the regulations from food standards Australia and new Zealand (FSANZ). The need of phytosterols has increased over the years due to increase death number to 43,603 which is nearly 30% of the total number in 2013. On the other hand, china, japan and India are also facing the similar health difficulties due to aging population and change in life style.

This report consists of insights of market based on segmentations on the parameters of product type, application type and geographical basis. The product type differentiations are Beta-sitosterol, Campesterol, and Stigmasterol. However the other elements include avenasterol, ergosterol, brassicasterol, lupeol, and cycloartenol. Moreover, the beta- sitosterol accumulated the largest market share in 2013 of 65.48% and is expected to grow in the next five years. The industry dominant companies include BASF, Archer Daniels Midlands (ADM), Raisio Life Sciences and Bunge Limited which are global best players and have a significant presence in Asia Pacific region as well.

This Report Offers:

1. Market Definition for the specified topic along with identification of key drivers and restraints for the market.

2. Market analysis for the Asia Pacific Phytosterols Market, with region specific assessments and competition analysis on a global and regional scale.

3. Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies, which can influence the market on a global and regional scale.

4. Extensively researched competitive landscape section with profiles of major companies along with their share of markets.

5. Identification and analysis of the Macro and Micro factors that affect the Asia Pacific Phytosterols Market on both global and regional scale.

6. A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

Why Buy This Report?

1. For getting a comprehensive overview of the Asia Pacific Phytosterols Market.

2. To gain wide-ranging information about the major players in this industry and the strategies adopted by them.

3. To gain an insight about the major countries/regions in which this industry is blooming and also identify the regions, which are untapped.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Introduction
1.1 Research Methodology
1.2 Definition of the Market
2. Key findings of the study
3. Market Overview
3.1 Introduction
3.2 Market Dynamics
3.2.1 Drivers
3.2.1.1 Increasing prevalence of heart diseases
3.2.1.2 Supportive regulatory environment
3.2.1.3 Increasing End-Use Applications
3.2.2 Restraints
3.2.2.1 Low consumer awareness
3.2.2.2 Side Effects of Phytosterols
3.2.3 Opportunities
3.2.3.1 Increased Health Consciousness
3.2.3.2 Technical innovations
3.2.4 Porter Five Forces Analysis
3.2.4.1 Bargaining Power of Suppliers
3.2.4.2 Bargaining Power of Buyers
3.2.4.3 Threat of New Entrants
3.2.4.4 Threat of Substitute Products and Services
3.2.4.5 Degree of Competition
4. Market Segmentation
4.1 By Application
4.1.1 Food Ingredients
4.1.2 Pharmaceuticals
4.1.3 Cosmetics
4.1.4 Others
4.2 By Product
4.2.1 Beta-sitosterol
4.2.2 Campesterol
4.2.3 Stigmasterol
4.2.4 others(avenasterol, ergosterol, brassicasterol, lupeol, and cycloartenol)
4.3 By Geography
4.3.1 South America
4.3.1.1 Brazil
4.3.1.2 Argentina
4.3.1.3 Others
5. Competitive Landscape
5.1 Mergers & Acquisitions
5.2 Joint Ventures
5.3 New Product Launches
5.4 Most active companies in the past five years
5.5 Market Share Analysis
6. Company Profiles
6.1 Raisio Plc
6.2 BASF
6.3 Bunge Limited
6.4 Archer Daniels Midland (ADM)
6.5 DuPont
6.6 Cargill
6.7 Arboris
6.8 Pharmachem Laboratories
6.9 Forbes Medi-Tech Inc.
6.10 Gustav Parmentier
6.11 Enzymotec Ltd.
6.12 Danone
6.13 Teriaka
6.14 Unilever
7. Appendix
7.1 Disclaimer
7.2 Sources
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll